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Abstract 
 Aging is a universal experience that is accompanied by increased risk for diseases like 
cancer and diabetes. Understanding the cellular basis of aging will therefore aid our 
understanding of these diseases and will allow us to better prevent and treat them.  Caloric 
restriction is a proven method of elongating lifespan not only in lower eukaryotes, like 
Saccharomyces cerevisiae (yeast), but also in mammals.  As there are conserved pathways that 
mediate the cellular adaptations to caloric restriction, model organisms are quite useful in 
elucidating the mechanisms involved.  This study utilized a yeast model system, due to ease of 
manipulation, genetic knowledge, and short lifespan.  One key adaptation to caloric restriction 
involves the nitrite dependent production of nitric oxide (NO) by the terminal enzyme in the 
electron transport chain, Cytochrome c oxidase (Cco).  Until recently, it was thought Cco only 
produced NO under conditions of hypoxia.  This study explores changes in Cco isoform 
switching, Cco subunit phosphorylation, and adenine nucleotide levels during caloric restriction, 
all of which could alter Cco’s oxygen sensitivity to allow for NO production.  Phosphorylation 
changes in subunit II of Cco and changes in ATP:ADP observed during caloric restriction appear 
to be regulatory mechanisms utilized by the cell to regulate Cco’s NO production, while isoform 
switching is not.  These findings help to solidify the role of AMP-activated protein kinase in 
mediating cellular adaptations to caloric restriction. 
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Introduction 
When Benjamin Franklin stated only death and taxes were certain, he overlooked another 
universal experience- aging.  Aging is defined by a time-dependent increase in cellular 
senescence beginning at reproductive maturity that will ultimately lead to the death of the 
organism, if uninterrupted.[1] Every organism ages, and they age in very similar ways, as 
characterized by an increasing mortality risk with age (Fig. 1).[2][3] While the effect of neuronal 
or endocrine systems on mammalian aging are not applicable in the aging of single-celled 
organisms like yeast, the intracellular changes seen during aging all have their counterparts in 
yeast.[4] This, coupled with easy genetic manipulation, vast genetic knowledge, and short 
lifespan, make Saccharomyces cerevisiae (yeast), a fantastic model organism with which to 
study aging.  As to how it is best to study aging and its intracellular effects, one method has been 
shown to be especially amenable- caloric (or dietary) restriction (CR). CR is the only 
intervention that extends lifespan in yeast, Caenorhabditis elegans, Drosophila melanogaster, 
and Macaca mulatta (rhesus monkey), where it was also seen to decrease the occurrence of age-
related diseases, such as cancer and cardiovascular disease, the top two causes of death in the 
US.[5][6][7] Elucidating the changes elicited by CR will provide insight to the pathways 
responsible for aging and age-related diseases, and yeast CR studies are directly relevant, more 
cost-effective, and less time-intensive. 
Theories about aging have long abounded. Half a century ago, Denham Harman proposed 
that that which gives us energy, the mitochondrion, also produces free radicals, primarily 
superoxide, that ultimately lead to our aging and demise, thus introducing the Free Radical 
Theory of Aging.[8]  This fit well with the understanding of aging being defined as a decrease in  
 Hendrickson 5 
 
!"
#!"
$!"
%!"
&!"
'!"
(!"
)!"
*!"
+!"
#!!"
!" $!" &!" (!" *!" #!!"
!"
#$
"%
&'(
)#
*+
*+
%,
'
-".#/'
!"
#!"
$!"
%!"
&!"
'!"
(!"
)!"
*!"
+!"
#!!"
!" '" #!" #'" $!" $'" %!" %'" &!" &'"
!"
#$
"%
&'(
)#
*+
*+
%,
'
0"%"#.12%/'
A. 
B. 
Figure 1. A. Survival curve of humans in US in 2006 (adapted from 
National Vital Statistics Report, 2010). B. Survival curve of yeast 
(adapted from Li et al., 2011). 
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cell functionality, which could readily be brought about by oxidative damage to cellular 
structures.  It was also in accordance with observations about lifespan in different organisms as it 
relates to respiratory rates, i.e. those with a higher cellular metabolic rate and therefore increased 
free radical production have a correspondingly shorter lifespan.[9]  Finally, it also made sense in 
the context of CR. CR is defined differently based on the organism being studied, however 
moderate CR normally consists of a 25-50% decrease in caloric consumption without nutritional 
deficiencies, with a typical yeast model using a decrease from 2% glucose media to 0.5% 
glucose media.[10]  It was hypothesized that a decrease in caloric intake would then also result 
in a decrease in respiration, which would lower the amount of damaging free radicals produced 
and elongate lifespan.[9]  
As our understanding of aging has evolved, so have the theories of aging.  When it was 
discovered that there are numerous agents, like peroxides and aldehydes, capable of producing 
oxidative stress besides free radicals, the theory shifted (in name only) to the Oxidative Stress 
Theory of Aging.[11]  Then it was found that mitochondrial DNA is especially vulnerable to 
oxidative damage, and mutations could decrease energy production while increasing free radical 
production, and the Mitochondrial Theory of Aging was born.[12]  While these theories of aging 
cast oxidative stress resulting from reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) as the cause of aging, the mechanistic details emerging from studies of CR were painting 
a more nuanced picture. 
In yeast, high glucose levels repress respiration and instead push metabolism towards 
fermentation.  Conversely, low glucose levels result in higher respiration levels.[13] This finding 
directly countered the previous theory that CR was leading to decreased respiration and therefore 
ROS production.   Altered rate of electron transfer then arose as a new explanation for the 
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decreased oxidative damage seen in CR.[14] ROS production primarily occurs in electron 
transport chain complexes I and III, and the rate of production increases with oxygen levels and 
the concentration of reduced electron donors. When there are more reduced electron donors, 
there is slower electron flow through the complexes, which gives increased opportunity for 
electrons to escape and form superoxide. The amount of reduced electron donors, such as 
NADH, is increased when there is high glucose availability.[15]   Therefore, although CR may 
increase respiration, it decreases the amount of ROS produced as a by-product. Even with this in 
mind, doubt is being cast on the relevance of ROS production as a mediator of lifespan, with 
evidence that both under and over expression of cellular antioxidants does not change lifespan, 
and even more contradictory, an abundance of antioxidants can reverse CR lifespan 
elongation.[16]  
To better understand the role of respiration and ROS in aging, further knowledge of the 
respiratory complexes was sought. Complex IV, or Cytochrome c Oxidase (Cco), of the 
respiratory chain is responsible for the reduction of O2 to H2O.  Cco is a multimeric membrane 
protein, comprised of three mitochondrially-encoded subunits and up to ten additional nuclearly 
encoded subunits.[17]  The binuclear reaction center composed of heme a3 and a copper B (CuB) 
is housed in subunit I, while a copper A (CuA) is bound by subunit II (Fig 2).  These are the sites 
of primary activity within the enzyme, however other subunits are involved in regulation.[18]  In 
yeast and other organisms, Cco also has a nitrite reductase activity under conditions of hypoxia, 
thereby producing nitric oxide (NO).  NO acts as a signaling molecule to induce a hypoxic 
response, primarily by stabilizing the transcription factor HIF-1!. Another response to hypoxia 
is an isoform switch, where subunit Va in Cco is switched for isoform Vb.  Vb has a higher NO  
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Figure 2. A labeled ribbon figure of yeast Cco’s structure, with bovine subunits 
superimposed (provided by Maréchal et al.) 
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turnover rate, and is thus a means of amplifying the hypoxic NO-signaling.[19]  Although the 
conversion of nitrite to NO by Cco is favored by hypoxia, it is now clear that this pathway is 
modulated and can function under normoxic conditions as well, such as during CR.  Even more 
astounding, the NO-production was found to be necessary for maximal lifespan elongation from 
CR.[3] Is it really possible that the very reactive species initially proposed to cause aging are 
actually fundamental agents in preventing it?  
Out of these insights, the concept of mitohormesis emerged, where a small amount of 
ROS/RNS initiates a protective effect, while large amounts are damaging.  In this framework, the 
slight increase in ROS/RNS production seen in CR would precondition the cell and activate 
stress responses, such as increased superoxide dismutase expression.  When significant ROS 
production occurs as a result of further stress, the cells are now better able to handle it, so the 
damage is minimized.[20]  ROS are so fundamental to the process of CR-induced lifespan 
extension that low levels of ROS production alone was sufficient to increase lifespan in yeast 
and C. elegans.[21] 
From here, the pathways upstream and downstream of the increased respiration and ROS 
production take the spotlight.  Upstream, nutrient sensing pathways like Tor have shown to be of 
import. Tor is a serine/threonine kinase that responds to changes in nutrient availability.  
Decreased signaling results in increased autophagy of damaged mitochondria, increased 
mitochondrial biogenesis, increased stress-response signaling via the transcription factors Msn2 
and Msn4, and increased respiration.[4] Decreasing Tor signaling will also prolong lifespan in 
yeast, in a manner dependent on ROS/RNS signaling.[22]  However, decreased activity in Tor 
alone is not equivalent to the changes brought about by CR, where there is a more global 
metabolic reprogramming of the cell that occurs which involves numerous pathways.[4]   
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One downstream pathway involves the deacetylase silent information regulator 2 (Sir2) 
in yeast, or Sirt1 in mammals.  Sir2 is involved in cellular stress and survival mechanisms, and 
therefore has an obvious place in CR-mediated lifespan increases.  Sir2 is NAD+-dependent and 
is activated by an increase in the ratio of NAD+ to NADH, which is seen when cells shift away 
from glycolysis, as in CR.  Sir2 is also inhibited by nicotinamide, and catabolism of nicotinamide 
increases during CR. As to how increased Sir2 activity leads to increased lifespan, one 
mechanism in yeast involves decreased formation of extra chromosomal rDNA circles that 
directly limit replicative lifespan.  Although this mechanism is unique to yeast, a similar process 
involving Sirt1 maintaining DNA integrity in humans is quite possible.[5]  Sir2 has also been 
shown to increase the activity of peroxisome proliferator-activated receptor gamma coactivator-
1! (PGC-1!), which in turn increases mitochondrial biogenesis.[16]   
Decreased insulin-like signaling has also been shown to increase lifespan in mice.  
Although the insulin-like pathway is not present in single-celled organisms like yeast, there are 
downstream factors of the insulin-like pathway that have homologs in yeast. AKT is a kinase 
involved in transducing insulin signaling and also in cellular survival mechanisms and it has a 
homolog in yeast, Sch9.  Increased Sch9 signaling has been shown to inhibit CR-mediated 
lifespan elongation, thus showing a conserved function for Sch9/AKT in CR.[5] Sir2 has also 
been implicated in the insulin secretory pathway, highlighting the importance of the molecular 
mechanisms of CR elucidated in model organisms for understanding the role of complex 
pathways in CR and aging in mammals.[23] 
While the role of NO in reprogramming cells during CR has yet to be established, it is 
clear that mitochondrial NO synthesis and respiration do play key roles.  Also unknown is how 
CR results in an increase in NO production by Cco, however there are several possibilities.  As 
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mentioned, there is a difference in activity between the two isoforms of subunit V in yeast 
(subunit IV in mammals).  Va is the aerobic isoform that produces NO only in conditions of low 
oxygen, while Vb is the anaerobic isoform that produces much higher levels of NO and shows 
less oxygen sensitivity.[19]   Therefore, it is possible that an isoform switch from Va to Vb is 
responsible for the increased NO production seen during CR.   
Another possibility is a change in allosteric regulation. Cco is a key modulator of electron 
flow rate through the electron transport chain, so it is the main site of regulation.[24]   Purified 
Cco has been shown to have variable oxygen reductase activity based on the concentration of 
adenosine triphosphate (ATP) and adenosine diphosphate (ADP), where high levels of ATP 
inhibit its activity.[25] It is therefore quite possible that a change in ATP and/or ADP 
concentration could also alter its nitrite reductase activity. As levels of ATP and ADP are 
responsive to nutrient availability, this seems a very plausible means of regulation.[26]   
Finally, there could be post-translational modifications to Cco, most likely through 
phosphorylation.  Phosphorylation of mammalian subunit IV-1 (homologous to yeast Va) in 
response to metabolic fluctuations has been established, as has phosphorylation of several other 
Cco subunits, including subunits I and II. These modifications can cause changes in respiration 
and allosteric regulation by ATP and ADP.[25]  Therefore, it is possible that the increased 
respiration associated with CR is the result of an activating phosphorylation, or the removal of an 
inhibitory phosphorylation.  Whether this change in phosphorylation state could also cause an 
increase in NO production has yet to be determined.  The location of the active site for nitrite 
reduction has not been fully determined, but has been assumed to be the binuclear reaction site 
responsible for O2 reduction.  However, there is another copper reaction center (CuA) present in 
Cco subunit II so it is possible that the nitrite reductase activity occurs there.[27] Ultimately,  
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there are dozens of possibilities for how phosphorylation could affect the activity of Cco and 
mediate the cellular response to CR and aging.  In this study, isoform switching, 
phosphorylation, and allosteric regulation are explored as possible explanations for the increase 
in NO production by Cco during CR (Fig. 3). 
 
Methods and Materials 
Yeast and media 
Yeast strains JM43 (MAT! his4-580 trp1-289 leu2-3, 112 ura3-52 ["+]), DW27, and 
DW29 were used.  DW27 and DW29 are both isochromosomal with JM43, but DW27 only 
expresses subunit Va of Cco, and DW29 only expresses subunit Vb.[28][19] YPD media was 
composed of 1% Bacto-yeast extract, 2% Bacto-peptone, and either 2% glucose (non-CR) or 
0.5% glucose (CR) and adjusted to pH 6.2.  The media was sterilized via autoclaving at 121oC 
for 15 minutes. Yeast were grown in a New Brunswick Scientific Excella E24 Incubator Shaker 
at 30oC and 200 rpm. Growth was measured using a Klett-Summerson Photoelectric Colorimeter 
with the assumption that a Klett of 100 corresponded to a cell density of 2.25 x 107 cells per mL, 
and that the relation between the Klett and cell density was linear. 
 
Mitochondrial Isolations 
Mitochondrial isolations were performed as previously described.[29]  Briefly, cells were 
harvested in mid-exponential phase, as determined by growth rates, and centrifuged at 4,000 rpm 
for 10 minutes.  The pellets were then resuspended in 20 mL 4oC dH2O and centrifuged at 5,000 
rpm for 10 minutes.  Prespheroplast buffer (1.21% Tris base and 0.04% dithiothreitol (DTT), pH 
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9.3) was added at 1 mL per 0.2 g cells, and this mixture was then incubated in a 28oC water bath 
at 100 rpm for 20 minutes. The mixture was then centrifuged at 5,000 rpm for 5 minutes and 
washed twice with 20 mL 4oC dH2O, centrifuging at 5,000 rpm for 5 minutes each time. 
Zymolyase in spheroplast buffer (0.14% NaH2PO4.H2O, 24.6% sorbitol, and 1 mM EDTA, pH 
7.5, with 5 mg zymolyase added per mL spheroplast buffer) was added at 0.6 mL per 1 g of cells.  
The mixture was incubated in a 35oC water bath at 100 rpm until the yeast were spheroplasted, as 
checked by their lysis upon immersion in dH2O and 2% N-lauroyl sarcosine and by microscopy.  
Spheroplasted cells were then centrifuged at 5,000 rpm for 5 minutes, and washed twice with 20 
mL post-spheroplast buffer (27.3% sorbitol, 1 mM EDTA, and 0.1% bovine serum albumin 
(BSA), pH 7.0).  Cells were resuspended in 10 mL lysis buffer with BSA (10.92% mannitol, 2 
mM EDTA, and 0.1% BSA, pH 7.4) and mixed in an Omnimixer (Omni International) for 3 
seconds at 1,000 rpm and 25 seconds at 20,000 rpm. The mixture was then centrifuged at 4,000 
rpm for 5 minutes.  The supernatant was decanted into new tubes and centrifuged at 10,000 rpm 
for 10 minutes. Again, the supernatant was decanted, and the pellet resuspend in 20 mL lysis 
buffer without BSA (10.92% mannitol and 2 mM EDTA, pH 7.0), and centrifuged at 3,700 rpm 
for 5 minutes.  The supernatant was then removed and centrifuged at 14,000 rpm for 10 minutes.  
The final pellet was resuspended in mannitol buffer (10.9% mannitol and 10 mM H3PO4, pH 7.0) 
and stored at -20oC until use.  
 
Protein Determination 
One part BSA standard or sample was combined with 15 parts 660 nm Pierce Protein 
Assay Reagent (Thermo Scientific) and incubated for 5 minutes.  The absorbance was measured 
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at 660 nm using a Molecular Devices SpectraMax M5 plate reader and the absorbance of the 
BSA standards was used to determine the unknown protein concentration.  
 
SDS-PAGE  
Isolated mitochondria were thawed and diluted into protein dissociation buffer (0.01 M 
NaPO4, 2% SDS, 4% glycerol, and 20 mM DTT).  The samples were then heated at 37oC for 30 
minutes and boiled at 100oC for 2 minutes. Bromophenol blue (0.05%) was then added at 5 µL 
per 100 µL dissociated sample.  A separating gel (2 mL glycerol, 5.76 g Urea, 500 µL dH2O, 5 
mL 1.5 M Tris-Cl, pH 8.8, 200 µL 10% SDS, 8 mL 40% polyacrylamide, 100 µL 10% 
ammonium persulfate (APS) and 6 µL TEMED) was poured and allowed to polymerize for 45 
minutes, followed by a stacking gel (3.25 mL dH2O, 50 µL 10% SDS, 1.25 mL 0.5 M Tris-Cl, 
pH 6.8, 438 µL 40% polyacrylamide, 50 µL APS, and 3 µL TEMED), which polymerized for 30 
minutes.  Ten µg of each sample was loaded into each well and the gel was run at 75 V until the 
dye front reached the top of the separating gel and then at 140 V until the dye front reached the 
bottom of the separating gel. 1X Tris-Glycine-SDS running buffer was used. 
 
Western Blot 
SDS-PAGE gels were transferred to PVDF membranes (wetted in methanol, then soaked 
in 1X Semi-Dry Buffer (Thermo)) using a Pierce Semi-Dry Blotter at 25V for 8 minutes. 
Membranes were then rinsed with dH2O and air-dried.  They were then rewet in methanol and 
blocked overnight in 5% non-fat milk in 1X PBS-T (1.418% Na2HPO4, 0.345% NaH2PO4.H2O, 
0.731% NaCl, and 1 mL 80% Tween per 1 L).  Membranes were then washed 4 times, 7 minutes 
each in 1X PBS-T and transferred to a solution containing 1:1,500 of primary antibody (rabbit or 
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mouse) in 5% non-fat milk in 1X PBS-T and incubated for 1.5 hours.  Again, membranes were 
washed 4 times, 7 minutes each in 1X PBS-T and transferred to a solution containing 1:20,000 of 
secondary anti-rabbit goat antibody or 1:10,000 of secondary anti-mouse goat antibody, 
conjugated to horseradish peroxidase, in 5% non-fat milk in 1X PBS-T and incubated for 1.5 
hours. Membranes were washed 4 times, 7 minutes each in 1X PBS-T then incubated in a 
solution containing 10 mL Western Lightning luminol reagent, 10 mL Western Lightning 
Oxidizing reagent (PerkinElmer), and 20 mL dH2O for 30 seconds. Membranes were then sealed 
airtight in plastic and exposed to film for varying amounts of time and developed. Antibodies 
used include one to a conserved region in subunit Va and Vb (DD-7), an anti- subunit II antibody 
(11-1B), and an anti-phospho-Ser58 (PhosphoSolutions). Quantification of bands was performed 
using ImageJ Software (National Institutes of Health). 
 
Sequence Alignment, Phosphorylation Site Prediction, and Protein Imaging 
Sequences were aligned using Uniprot (European Bioinformatics Institute, the SIB Swiss 
Institute of Bioinformatics, and the Protein Information Resource) and phosphorylation sites 
predicted using the Eukaryotic Linear Motif.[30][31] Protein structures were imaged using 
DeepView.[32] 
 
Nitric Oxide Production Measurements 
NO measurements were made using the inNOII Nitric Oxide Detector and an amino-700 
electrode (Innovative Instruments, Inc.).  For NO measurements, JM43 yeast were grown in 
either 2% or 0.5% YPD.  Samples were spun down at 10,000 rpm for 10 minutes, and then 
washed in water and spun down again at 14,000 rpm for 5 minutes. Whole cells were suspended 
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in a thermostated chamber set to 30oC at a concentration of 85 mg/mL in 1X-PBS pH 6.5, for a 
total volume of 1 to 2 mL. 
 
Ascorbate-TMPD Assay 
The Ascorbate-TMPD assay was completed as previously described.[33]  Briefly, 50 µg 
of solubilized mitochondria were suspended in a thermostated chamber set to 30oC containing 2 
mL of assay buffer (75 mM mannitol, 25 mM sucrose, 100 mM KCl, 10 mM KH2PO4, 10 mM 
Tris, 50 µM EDTA, pH 7.4).  After 10 minutes of incubation, 5 kU of superoxide dismutase 
(SOD) was added. One minute later, 10 uM of yeast cytochrome c (Sigma) was added.  After 
another minute, ascorbate was added to a final concentration of 0.5 mM.  Finally, TMPD was 
added to a final concentration of 0.5 mM. The chamber was allowed to reach anoxia, and then 40 
µL of nitrite (NO2-) was added and NO production measured using an animo-700 electrode and 
the inNOII Nitric Oxide Detector.  To measure the effects of phosphorylation on nitrite reductase 
activity either alkaline phosphatase (Sigma) or a phosphatase inhibitor cocktail (Sigma) was 
added to the assay buffer prior to adding the mitochondria. 
 
Glucose Assay 
JM43 yeast were grown in 2% or 0.5% YPD and cell density was determined using a 
Klett-Summerson Photoelectric Colorimeter. Samples were taken immediately after inoculation 
and then subsequently every 30 minutes for 6.5 hours.  Samples were centrifuged at 5,000 rpm 
for 10 minutes and the cells were removed.  Media was stored at -20oC until use. Media glucose 
concentrations were assessed using the Sigma Glucose (Glucose Oxidase) Assay Kit, as 
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described.  Briefly, samples were diluted 1:511 in dH2O and mixed with the assay reagent, which 
consisted of Glucose Oxidase/Peroxidase and o-Dianoside.  The assay was allowed to incubate 
for 30 minutes and then the reaction was halted using 12 N H2SO4. Absorbance was measured at 
540 nm using a Molecular Devices SpectraMax M5 plate reader.  Glucose concentrations were 
quantified based off the absorbance of the glucose standards.  
 
ATP and ADP Effects on Cco/NO Activity 
Fifty µg of isolated mitochondria were solubilized in 200 mM Tris pH 7.0 and 0.5 mM 
dodecyl-#-D-Maltoside, with a final reaction volume of 2 mL. Differential concentrations of 
ATP or ADP were then added, with the concentration of ATP being held constant by a 
regenerating system (10 mM phosphoenolpyruvate, 10 U/mL pyruvate kinase, 5 mM MgSO4, 
and varying amounts of MgATP).  NO production was then measured using the Ascorbate-
TMPD assay described above. 
 
Nucleotide Extraction 
JM43 yeast were grown in 2% or 0.5% YPD.  Samples containing 5x107 cells were taken 
and centrifuged at 14,000 rpm for 5 minutes and the media removed. The cells were then washed 
three times with dH2O at 14,000 rpm for 5 minutes and either flash frozen in dry ice and stored at 
-80oC or stored at -20oC until use. Cells were then lysed by various methods. One extraction 
method involved boiling the cells to release the adenine nucleotides.[34]  Briefly, 1.5 mL 100oC 
dH2O or 0.1 M Tris-EDTA buffer pH 7.75 (TEB) was added to samples.  Samples were then 
placed in boiling water for 10 minutes with vortexing every minute. Cellular debris was then 
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spun out at 14,000 rpm for 5 minutes and the supernatant saved.  Samples were stored on ice or 
frozen at -20oC until assayed. A separate method used trichloroacetic acid (TCA) to denature the 
cells.[35]  An ice-cold 10% TCA and 4mM EDTA solution was added to the frozen samples in 
equal parts (5.7 µL) for a final concentration of 5% TCA and 2 mM EDTA.  Cells were then 
vortexed and after 5 minutes, the extraction diluted to a final volume of 1.5 mL either using 
dH2O or TEB. Again, cellular debris was then spun out at 14,000 rpm for 5 minutes and the 
supernatant saved. Samples were then stored on ice or frozen at -20oC until assayed. To 
determine ADP concentrations, a 200 µL aliquot of cell extract was removed. The aliquot 
received 200 µL of a solution of 200 mM triethanolamine pH 7.6, 2 mM MgCl2, 240 mM KCl, 
4.6 mM phosphoenolpyruvate (Sigma), and 5 U/mL pyruvate kinase (Sigma). The mixture was 
incubated at 37oC for 10 minutes and then placed on ice or frozen at -20oC until use.[34] 
 
ATP and ADP Assay 
ATP levels were assessed using the Molecular Probes’ ATP Determination Kit (A22066) 
as per manufacturer instructions.  Briefly, a standard reaction solution comprised of 8.9 mL 
dH20, 0.5 mL 20X Reaction Buffer (500 mM Tricine buffer pH 7.8, 100 mM MgSO4, 2 mM 
EDTA, and 2 mM sodium azide), 0.1 mL 10 mM DTT, 0.5 mL 10 mM D-luciferin in 1X 
Reaction Buffer, and 2.5 µL firefly luciferase (5 mg/mL) was prepared and kept on ice and 
protected from light.  ATP standards of 0.25 µM, 0.5 µM, 0.75 µM, and 1 µM were prepared in 
dH2O.  For ATP determination, 10 µL sample or standard and 90 µL standard reaction solution 
was added to each well and the luminescence was measured using a Molecular Devices 
SpectraMax M5 plate reader over a 5-minute period. For ADP determination, 10 µL of each 
sample incubated with pyruvate kinase was then added to a well with 90 µL standard reaction 
 Hendrickson 20 
solution and the luminescence was again measured over a 5-minute period.  The measured 
luminescence of the unreacted samples was then subtracted from that of the reacted samples in 
order to determine the ADP concentration.  Final extraction volumes were considered when 
analyzing the raw data to account for unintended volume variations, and a cell count of 5 x 107 
and cell radius of 3 µm were assumed. 
 
Results 
Isoform Switching Does Not Occur During CR 
Previously, it has been reported that the two isoforms of subunit V have differential 
effects on both the activity and oxygen sensitivity of NO synthesis by Cco.[19] The subunit Vb 
isoform increases Cco nitrite reductase activity (Cco/NO) and decreases oxygen sensitivity, 
allowing NO production in normoxic conditions.  Subunit Vb is expressed predominantly during 
hypoxia, has a higher NO turnover rate, and its increased expression during CR could account 
for the increased NO production seen. To test for a change in subunit V isoforms during CR, 
SDS-PAGE was performed using isolated mitochondria from mid-exponential phase CR and 
non-CR JM43, with DW27 and DW29, strains that only express Va or Vb, as controls.  The gels 
were transferred to a membrane and blotted with an anti-subunit V antibody that recognizes both 
Va and Vb. No expression of subunit Vb was observed in JM43 yeast grown in 2% or 0.5% 
media (Fig. 4a). A 3.3-fold average increase in expression of subunit Va was seen in JM43 yeast 
grown in 0.5% YPD as opposed to yeast grown in 2% YPD (Fig. 4b).    To see whether this 
increase was also seen for other Cco subunits, levels of subunit II were quantified.  A 3.4 average 
increase in subunit II levels was seen in CR JM43 yeast as opposed to non-CR JM43 yeast (Fig.  
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A. 
           1               2               3             4 
  Va            N.A.         N.A.           1        3.3± 1.24 
  Vb           N.A.         N.A.           0              0 
B. 
Figure 4. A. Western Blots comparing the 
relative levels of Va and Vb in CR and non-CR 
yeast (1- DW27, 2-DW29, 3- non-CR JM43, 4- 
CR JM43) show no increase in Vb expression 
during CR. 
B. A comparison of relative levels of subunit Va 
in CR (0.50% glucose) and non-CR (2% glucose) 
JM43 yeast shows expression of Va increases 3.3-
fold during CR. 
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Figure 5. Western Blots comparing 
relative amounts of subunit II in CR 
(0.5% glucose) and non-CR (2% glucose) 
JM43 yeast show that expression of 
subunit II increases 3.4-fold during CR. 
    1       3.4±1.1  
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5).  Given that roughly the same relative increase was seen for subunit Va and subunit II 
expression (3.3 vs 3.4), this suggests an overall increase in Cco expression during CR. 
 
NO Production Decreases with Added Phosphatases and Increases with Phosphatase 
Inhibitors 
Using the ascorbate- TMPD assay to measure Cco’s nitrite reductase activity, either alkaline 
phosphatases or phosphatase inhibitors were added to JM43 mitochondria isolated during mid-
exponential phase.  The addition of phosphatase inhibitors led to a 7.5-fold increase in NO 
production compared to the addition of phosphatases in non-CR mitochondria and a 8.75-fold 
increase in NO production in CR mitochondria (Fig. 6). This suggests that a key site of 
regulation in increasing nitrite reductase activity (or decrease oxygen sensitivity) is regulated via 
phosphorylation.  This change would happen quite rapidly in response to CR, and thus changes 
in cells recently switched to CR should be evaluated, as opposed to those in mid-exponential 
phase. 
 
Phosphorylation of Subunit II Changes in CR 
Numerous phosphorylation sites have been identified in bovine Cco subunits.  As there is a large 
degree of homology in subunits 1 and II, there is a good possibility that key regulatory 
phosphorylation sites will be conserved in yeast.  An alignment of yeast subunit I with bovine 
subunit I showed high levels of conservation.  Phosphorylation of mammalian subunit I has been 
established at serine 115 and 116, and there are corresponding serines/threonines in yeast.  The 
next known phosphorylation site on subunit I is tyrosine 304, which not only is conserved in 
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Figure 6. NO production by Cco in CR (0.50% glucose) and non-CR 
(2% glucose) JM43 yeast, with added phosphatases or phosphatase 
inhibitors. NO production in the presence of phosphatase inhibitors 
increases 8.75-fold above levels in the presence of phosphatases in CR 
JM43 and increase 7.5-fold in non-CR JM43 (provided by Andrew 
Nelson). 
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yeast, but the surrounding amino acids are also highly conserved, suggesting this could be an 
important point of regulation (Fig. 7a).  In an alignment of bovine subunit II with yeast subunit 
II, the only known site of phosphorylation in bovine subunit II, serine 126, does not have a 
conserved serine in yeast.  There is a site of serine conservation at the -6 site from serine 126, 
however that is not a known phosphorylation site.  A predicted phosphorylation site on yeast 
subunit II falls at threonine 15 (Fig. 7b).  It is predicted that a proline directed kinase, such as 
MAP Kinase, could phosphorylate this site.  This corresponds to serine 14 in both bovine subunit 
II and human subunit II.  Importantly, they also all retain the +1 proline, which is required for 
MAPK phosphorylation and are all located in the mitochondrial intermembrane space, and 
therefore accessible to MAPK.  An alignment of subunit IV-1 in humans with subunit Va in 
yeast shows possible conserved sites of phosphorylation.  Serine 58 is a key site of regulation for 
IV-1, and when it is phosphorylated, ATP is less capable of inhibiting Cco’s activity.[33]  There 
is a nearby serine 51 in yeast Va that could be a corresponding site of regulation in yeast. There 
is also a phosphorylation site at serine 136 in IV-1 that has a corresponding serine 141 in yeast 
Va, which could be another site for phosphorylation (Fig. 7c).[36] Using an anti-phosphoserine 
antibody, phosphoproteins were identified in CR and non-CR yeast. The bands were identified 
based on comparison with antibodies to specific subunits and then relative levels were 
quantified.  The only bands readily identifiable corresponded to subunit II.  CR JM43 
mitochondria showed 1.6-fold higher levels of phosphorylated subunit II (Fig. 8).  The 
differences between CR and non-CR mitochondria did not initially appear significant, as there 
were fairly similar relative levels.  However, given the different levels of Cco, if phosphorylation 
patterns were consistent in CR and non-CR mitochondria, then there should be an increased 
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1   MLATRVFSLVGKRAISTSVCVRAHESVVKSEDFSLPAYMDR--RDHPLPEVAHVKHLSAS    58  IV-1 (human) 
1   ML-RNTFTRAGGLSRITSVRFAQ------THALSNAAVMDLQSRWENMPSTEQ----QDI    49  Va   (yeast) 
  **  ..*: .*  :  *** .        :. :*  * **   * . :*.. :    . 
59  QKALKEKEKASWSSLSMDEKVELYRIKFKESF---AEMNRGSNE--WKTVVGGAMFFIGF   113  IV-1   
50  VSKLSERQKLPWAQLTEPEKQAVWYISYGEWGPRRPVLNKGDSSFIAKGVAAGLLFSVGL   109  Va 
   . *.*::*  *:.*:  **  :: *.: *       :*:*...   * *..* :* :*:  
114  TALVIMWQKHYVYGPLPQSFDKEWVAKQTKRMLDMKVNPIQGLASKWDYEKNEWKK      169  IV-1         
110  FAVVRMA-----GGQDAKTMNKEWQLKSDEYLKSKNANPWGGYSQVQSK-------       153  Va  
  *:* *       *   ::::***  *. : : . :.**  * :.  .  
1  ----------------MAYPMQLGFQDATSPIMEELLHFHDHTLMIVFLISSLVLYIISL   44  II  (bovine)  
1  MLDLLRLQLTTFIMNDVPTPYACYFQDSATPNQEGILELHDNIMFYLLVILGLVSWMLYT   60  II  (yeast) 
      :  *    ***:::*  * :*.:**. :: :::* .** ::: 
Figure 7. A. Excerpts from an alignment of bovine subunit I and yeast subunit I shows a conserved site of phosphorylation at serine 
115 and 116 and tyrosine 304.  B. Excerpts from an alignment of bovine subunit II and yeast subunit II shows no conservation of the 
phosphorylation site serine 126 in yeast.  Threonine 15, which was identified as a target for MAPK phosphorylation, is highly 
conserved.  C.  An alignment of human subunit IV-1 and its homolog in yeast, Va shows some conservation of both serine 58 and 
136 in yeast. Known phosphoylation sites are in green, potential conserved phosphorylation sites in yeast are in red, and predicted 
phosphorylation sites are in blue. (*-fully conserved, :-highly conserved, .-semi conserved)  
A. 
B. 
101  GHQWYWSYEYTDYE-----DLSFDSYMIPTSELKPGELRLLEVDNRVVLPMEMTIRMLVS  155  II  
121  GYQWYWKYEYSDFINDSGETVEFESYVIPDELLEEGQLRLLDTDTSMVVPVDTHIRFVVT  180  II 
 *:****.***:*:       :.*:**:** . *: *:****:.*. :*:*::  **::*: 
299  VDTRAYFTSATMIIAIPTGVKVFSWLATLHGGNIKWSPAMMWALGFIFLFTVGGLTGIVL  358  I 
299  ADTRAYFTSATMIIAIPTGIKIFSWLATIHGGSIRLATPMLYAIAFLFLFTMGGLTGVAL  358  I 
 .******************:*:******:***.*: :  *::*:.*:****:*****:.* 
C. 
59  TAHAFVMIFFMVMPIMIGGFGNWLVPLMIGAPDMAFPRMNNMSFWLLPPSFLLLLASSMV  118  I   (bovine) 
60  VGHAVLMIFFLVMPALIGGFGNYLLPLMIGATDTAFPRINNIAFWVLPMGLVCLVTSTLV  119  I   (yeast) 
 ..**.:****:*** :******:*:****** * ****:**::**:** .:: *::*::* 
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Figure 8. Western blotting indicates subunit II 
is phosphorylated both during CR (2% 
glucose) and non-CR (0.50% glucose). Levels 
of phosphorylated subunit II are 1.6-fold 
higher in CR JM43 (0.50%) than non-CR 
JM43 (2%). 
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signal (roughly 2x of what was seen) of phosphorylated subunit II in CR mitochondria 
corresponding to the increased expression of subunit II (Fig. 5). 
 
ATP and ADP Both Affect Cco/NO Activity 
It has been established that adenine nucleotides can allosterically affect the rate of 
respiration.[37]  It is therefore possible that Cco/NO is also subject to allosteric modulation by 
ATP and ADP.  To explore this, NO production by Cco was measured in the presence of added 
ATP or ADP.  When ATP levels increased, Cco/NO activity decreased, as measured by the 
ascorbate-TMPD assay.  The decrease plateaued at roughly 65% baseline activity beginning at 
12.5 mM ATP. Conversely, when ADP levels increased, Cco/NO activity did too.  Again, 
activity responded to changes up until roughly 260% activation above baseline at 17.5 mM ADP 
(Fig. 9).  As Cco’s ability to reduce O2 is also affected by high ATP levels, this introduces a 
plausible mechanism by which both O2 consumption and NO production increase during CR.  
This also suggests that changes in response to CR would occur quite rapidly within the cell, and 
that earlier time points should be analyzed to observe initial changes. 
 
Early Events in the Activation of Cco/NO during CR 
 As indicated by previous results, the cellular adaptations to CR are rapidly inducible.   
Therefore, NO production and ATP and ADP levels were assessed immediately following a 
switch from stationary phase and no glucose to 2% or 0.5% media.  This methodology allowed 
for the time frame of NO production and the response to CR to be established.   
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Figure 9. Cco/NO activity is affected by both ATP and ADP levels. ATP maximally 
inhibits baseline Cco/NO by 35%, while ADP maximally activates Cco/NO by 260% 
(adapted from Pablo Castello). 
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I. Changes in Glucose Levels During the Growth of CR and non-CR JM43 
First, glucose concentrations during growth were measured to ensure that there was a 
sufficient difference in glucose concentrations between CR and non-CR media during 
subsequent measurements of NO production and ATP/ADP levels.  Media glucose levels were 
determined using a colorimetric assay.  In 2% (non-CR) media, glucose levels remained above 
80% of their initial value at a cell density below 9.9 x 106 cells/mL (Fig. 10a).  In 0.5% (CR) 
media, glucose levels remained above 80% of their initial value at a cell density below 6.98 x 106 
cells/mL (Fig. 10b).   
II. Changes in Mitochondrial NO Synthesis During the Growth of CR and non-CR JM43 
While NO production in mid-exponential phase cells has been established, the time point 
at which NO production increases has yet to be determined.  Cells were harvested at various time 
points after a switch to 0.5% media.  NO production was then measured in the presence and 
absence of added nitrite.  Exogenous nitrite was added to observe whether NO production was 
limited by Cco/NO’s rate of reaction or by a lack of nitrite. At 30 minutes after the shift, NO was 
produced at a rate of 0.176 nM per second per gram of cells (wet weight) with and without nitrite 
in CR JM43.  In CR JM43 at 90 minutes, NO was produced at a rate of 0.147 nM s-1 g-1 without 
nitrite and 0.157 nM s-1 g-1 with added 1 mM nitrite.  At 120 minutes, NO was produced at a rate 
0.072 nM s-1 g-1 with and without nitrite in CR JM43.  At 210 minutes, CR JM43 produced 0.07 
nM NO s-1 g-1 without nitrite and 0.08 nM NO s-1 g-1 with 1 mM added nitrite (Fig. 11). 
Preliminary data of NO production in non-CR JM43 shows no NO production during these early 
time points, even with added nitrite.  However, they will produce NO during anoxia, indicating 
the necessary components are in place, but the oxygen sensitivity is much higher than in CR 
JM43 (data not shown). 
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Figure 10. A.  Glucose concentration (x) and cell density (!) as a function of time for JM43 yeast in 2% YPD (non-CR). Glucose 
concentrations do not depreciate considerably until 200 minutes. 
B. Glucose concentration (x) and cell density (!) as a function of time for JM43 yeast in 0.50% YPD (CR). Glucose concentrations 
do not fall as rapidly as seen in non-CR growth, with non-CR yeast taking half the time of CR yeast to consume 5 mg/mL glucose. 
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Figure 11.  NO production in CR JM43 both 
without nitrite (!) and with 1mM added nitrite 
(!) shows a rapid induction that declines over 
time, suggesting transient NO production as a 
means of signaling. 
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III. Changes in Adenine Nucleotide Levels During the Growth of CR and non-CR JM43 
 A. Boiling Samples in Buffer Results in the Highest Adenine Nucleotide Extraction 
 Numerous methods have been published pertaining to extracting free nucleotides from 
whole cells.[34][35] Each method involves a delicate balance of lysing cells and inactivating 
enzymes either via physical or acid disintegration, while ensuring ATP and ADP are not 
destroyed in the process.  This problem is compounded in cells containing a cell wall, such as 
yeast, as even more vigorous methods of disintegration are required to extract ATP.  For this 
reason, several sample storage methods and extraction preparation techniques found in the 
literature were tested. For storage, cell samples were either stored at -20oC or frozen on dry ice 
and then stored at -80oC until extraction.  For preparations, samples were either boiled in 1.5 mL 
dH2O or TEB or extracted in 5% TCA and 2 mM EDTA and then diluted to 1.5 mL with dH2O 
or TEB.  Extraction/dilution in dH2O resulted in much higher yields of ADP than ATP, which is 
physiologically inconsistent, as the amount of ATP in the cell must be higher than ADP when 
cells are viable, therefore extraction/dilution in dH2O was leading to preferential degradation of 
ATP.  Extraction/dilution in TEB led to a much higher yield of ATP, and suggested more 
physiologically plausible ratios, indicating buffer be used (Fig. 12a).  Samples that were stored at 
-20oC showed higher yields, specifically of ATP, than did samples frozen on dry ice and then 
transferred to -80oC (Fig. 12b).  This is an interesting discovery, as it was expected that cells 
frozen at -20oC would be able to respond to the stress of the cold more so than the cells frozen in 
dry ice, and would therefore have relatively lower ATP levels.   Ultimately, boiling samples in 
TEB resulted in the highest extraction, and was therefore the method used henceforth (Fig. 12c).   
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Figure 12. A. Comparison of ATP extraction in dH2O (!) or in Tris-EDTA buffer (TEB) (!) when boiling or using 5% TCA showed TEB to be 
more effective.  B.  Comparison of ATP extraction when freezing cells and storing them at -20oC (!) or freezing them on dry ice and storing them 
at -80oC (!) when boiling in TEB or using 5% TCA and diluting into TEB. Freezing at -20oC produced the highest yields of ATP.   C. Comparison 
of ATP and ADP extractions when boiled in TEB (!) or using 5% TCA and diluting into TEB(!). Boiling in TEB resulted in higher extraction of 
ATP, and both methods showed equal ADP extraction.  
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B. Increases in ATP, ADP Levels Persist Longer in CR JM43 
The ratio of ATP to ADP in yeast has previously been found to be close to 2, though it 
can change rapidly in response to multiple factors, including nutrient availability.[38]  To test 
what the effect of CR is on the concentration of ATP and ADP, JM43 yeast were grown in 2% or 
0.5% media and 5x107 cells taken per sample, with samples taken over the course of 6 hours.  
Both 2% and 0.5% yeast showed an immediate rise in ATP levels (Fig. 13a and 13b). The 
increase quickly subsided and ATP levels fell below their starting values for non-CR yeast.  
Non-CR yeast also showed a brief, rapid increase in ADP levels followed by a depression (Fig. 
13a).  In CR yeast, the increase in ATP was slower to reverse and ADP levels held much more 
constant in the initial 2 hours, though there was an initial decrease (Fig. 13b).  After 6 hours, 
ATP and ADP levels were very similar in CR and non-CR yeast (Fig. 13a and 13b).   The ratio 
of ATP to ADP was found to oscillate, with an average value slightly above 2 for both CR and 
non-CR yeast.  Immediately after the switch, ATP:ADP increased 2-fold in CR JM43, while a 
much smaller increase was observed in non-CR JM43 (Fig. 14). 
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A. 
B. 
Figure 13.  A. Time-dependent concentrations of ATP (!) and ADP (") in JM43 switched to 2% media (non-CR). After a brief peak at 10 
minutes, both ATP and ADP levels declined before returning to close to their starting values.  B. Time-dependent concentrations of ATP (!) and 
ADP (") in JM43 switched to 0.50% media (CR).  ATP levels had a more sustained peak beginning at 10 minutes than seen in non-CR media, 
but also eventually declined below its initial value and then returned to close to its starting value.  ADP concentration briefly dipped at 10 
minutes but then remained very close to its starting value until 200 minutes, when it declined.  After 200 minutes ADP values rose again and 
returned to around its starting value. 
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Figure 14. The ratio of ATP to ADP in both non-CR (!) and CR (") JM43 in highly 
variable, but averages to slightly above 2 in both groups.  Immediately after the switch, 
CR JM43 had a 2-fold increase in ATP:ADP, which was 1.6 times higher than the 
increase seen in non-CR JM43. 
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Discussion 
 This study focused on answering how Cco/NO’s oxygen sensitivity is altered in CR to 
allow NO production during normoxia.  An isoform switch of Cco subunit V, phosphorylation of 
Cco, and allosteric regulation of Cco by adenine nucleotides were all explored as possible 
mechanisms.   
 
Isoform Switching 
Though an isoform switch between Va and Vb makes sense based on previous 
observations about their different oxygen sensitivities, there is no increase in Vb expression 
during CR.[3] Rather, an increase in Va levels was seen during CR.  A similar increase was seen 
in subunit II expression, indicating a rise in Cco subunits relative to other proteins.  Although 
mitochondrial biogenesis does increase during CR, isolated mitochondria were run, so the 
increase of Cco is in relation to mitochondrial protein levels.  Even considering the increased 
expression, Va has high oxygen sensitivity, so some other change must occur that causes the 
increase in NO production in normoxia during CR.[19]  
 
ATP and ADP Allosteric Modulation of Cco/NO 
The data on ATP and ADP regulation of Cco/NO shows that, much like respiration, its 
activity was indeed affected by ATP and ADP concentrations. ATP has a mild inhibitory effect 
on Cco/NO, while ADP can activate it 2.6-fold. Concentrations of ATP had to be above 2.5 mM 
in order to see any inhibition, while there was an immediate, rapid rise in activation based on 
ADP.  This contrasts the data on ATP and ADP’s effects on respiration, where there was a larger 
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inhibitory effect of ATP than an activating effect of ADP on respiration, though they were fairly 
close.[38] Also, considering the highest ATP concentration seen during the ATP and ADP Assay 
was 0.25 mM, it is possible that allosteric regulation of Cco/NO is more of activation by ADP 
than inhibition by ATP, as ATP would not be high enough intracellularly to inhibit Cco’s 
activity.  However, it is also important to note the limitations of the ATP/ADP assay; it assumed 
a certain cellular size and uniform ATP and ADP distribution within the cell. In reality, vacuoles 
and endosomes, devoid of any ATP or ADP, can take up variable amounts of space within yeast, 
which would mean concentrations of ATP and ADP were higher intracellularly than reported 
here.[39]  
Even considering the problems inherent in precise quantification of ATP and ADP 
concentrations, the data obtained on ATP and ADP levels six hours following a switch from 
stationary phase to high or restricted glucose show the relative changes of these nucleotides.  The 
relative change seems to counter the hypothesis that ATP:ADP should decrease during CR.  
Instead an immediate peak in ATP is seen both in CR and non-CR yeast.   The peak rapidly 
subsides in non-CR yeast and after a dip, ATP levels return to roughly their starting value.  For 
CR yeast, the peak in ATP levels is less quick to subside, and instead slowly tapers off, followed 
by a brief dip and then a return to their initial value.  For ADP, the pattern in non-CR yeast is 
very similar to that of ATP.  In CR yeast, ADP has a brief dip, but then remains relatively stable 
for an hour, before taking the dip taken by all the others and then stabilizing near initial values. 
In some way, this is the expected response, as respiration yields higher ATP than does 
glycolysis.[40] If ATP inhibits both Cco’s oxygen and nitrite reductase activity, why then do 
ATP levels increase in CR cells that also have higher levels of respiration and NO production?  
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The likely answer to this question involves phosphorylation that could abolish Cco’s ATP 
sensitivity in CR. 
 
Phosphorylation Effects on Cco/NO 
The difference in NO production between JM43 mitochondria treated with phosphatases 
and mitochondria treated with phosphatase inhibitors was quite large for both CR and non-CR 
mitochondria, with CR mitochondria showing a 8.75-fold average increase and non-CR 
mitochondria showing a 7.5-fold average increase.  This difference indicates an important role 
for phosphorylation in modulating the NO production of Cco.  Although subunit Va is an 
obvious site of such phosphorylation, the results did not show any phosphorylation of Va, and in 
fact only showed phosphorylation of subunit II. 
 
Potential Phosphorylation Sites 
Based on a western blot using an anti-phosphoserine antibody, subunit II appeared to be 
differentially phosphorylated in CR and non-CR mitochondria.  Therefore, it is possible that the 
decrease of phosphorylation seen on subunit II during CR plays an important role in the oxygen 
sensing of Cco/NO. Subunit II houses copper A (CuA), which accepts electrons from cytochrome 
c and then passes them to heme a.  They are then transferred to heme a3 and copper B (CuB), 
which together compromise the binuclear reaction center that ultimately reduces O2 to H2O.[41]  
Subunit II is therefore the interface between the intermembrane space and the binuclear reaction 
center in subunit I (Fig. 2).[42]  Given this role, a site of regulation via phosphorylation on 
subunit II makes good sense. 
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As indicated in figure 7b, there is a known phosphorylation site on subunit II, serine 126. 
The group that initially identified this phosphorylation site on subunit II proposed it could be 
involved in regulation of ATP’s allosteric effects, as it is proximal to subunit Va in yeast, which 
is known to house the ATP/ADP binding site.  Here, it is important to note that although 
phosphorylation is required for ATP to inhibit respiration, with serine 126 on subunit II proposed 
to enable it, phosphorylation at serine 58 on subunit IV (mammalian) abolishes ATP’s ability to 
bind Cco.[43]  Therefore, a careful balance of phosphorylation and dephosphorylation coupled 
with allosteric effects regulate Cco’s activity in respect to respiration.  Is this also the case with 
Cco’s nitrite reductase activity? The evidence for allosteric regulation of Cco/NO by ATP and 
ADP, increased NO production upon inhibition of phosphatases, and decreased phosphorylation 
of subunit II during CR indicate that it is.  As with most cellular processes, there is no one 
phosphate group or allosteric effect that accounts for all changes seen, and the changes in 
respiration and NO production could be the result of a phosphate added to one site, like Va, and 
lost from another, like subunit II.  
The question again returns to where these key phosphorylation sites are within Cco.  
Although the data here do not show any phosphorylation of subunit Va, it is an established site of 
Cco regulation and should be afforded due consideration. Subunit Va has a key role in 
establishing oxygen sensitivity of Cco’s nitrite reductase activity and modulating allosteric 
effects of ATP and ADP, as organisms that lack a subunit V homolog, such as prokaryotes, do 
not show inhibition by ATP.[44]  Phosphorylation of serine 58 on subunit IV-1 in mammals 
abolishes allosteric inhibition by ATP, however it still allows allosteric modulation by ADP.  
Serine 58 is located in the mitochondrial matrix, and thus requires a matrix kinase for 
phosphorylation.  Mitochondrial adenylyl cyclase generates cAMP, which activates 
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mitochondrial PKA, and PKA then phosphorylates serine 58.  Once phosphorylated, subunit IV-
1 can no longer bind ATP.  This phosphorylation allows for increase oxidative phosphorylation 
during periods of high growth, as demonstrated by serine 58 mutants that show decreased 
growth.[25]  This appears to be a key phosphorylation site in the response to CR, as it would 
allow Cco to ignore the high ATP levels but respond to the increase in ADP with an increase in 
respiration and NO production.  It is possible that this phosphorylation slightly lowers Va’s 
oxygen sensitivity and that this, coupled with overall higher levels of Cco, leads to the increase 
in NO production.  This becomes even more plausible considering that ATP levels drop and 
ADP levels rise during hypoxia, as glycolysis produces less ATP per glucose.[45]  Although 
serine 58 is not conserved in yeast, there is a proximal serine 52 that could potentially serve the 
same purpose in yeast.  
Subunit II is another potential site for regulation.  As mentioned, serine 126 on subunit II 
is an identified phosphorylation site.  This site is not conserved in yeast, however.  A search for 
potential phosphorylation sites identified a mitogen activated protein kinase (MAPK) consensus 
sequence at threonine 15 in yeast or serine 14 in mammals.  Without further analysis, it cannot 
be determined whether the difference observed in phosphorylation on subunit II was due to 
threonine 15 or another phosphorylation site.  If it was threonine 15, and if it was phosphorylated 
by MAPK, the mechanism would be in accord with other known pathways in CR.  In yeast, 
MAPK regulates several stress responses, such as starvation.  In mammals, MAPK’s function is 
similar as it is involved in stress responses, like cell survival and apoptosis.  It is also involved in 
insulin-like signaling.[46]  Therefore, decreased phosphorylation by MAPK during CR would be 
assumed, as there is lower insulin-like signaling via Sch9 in yeast.  As to what effect the 
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phosphorylation of threonine 15 could have on Cco activity, it would make the most sense for it 
to allow ATP inhbition or otherwise decrease Cco activity.   
Finally, there is the phosphorylation site on tyrosine 304 in subunit I.  Like with subunit 
Va, although subunit I was not identified as phosphorylated via western blotting, it has a known 
phosphorylation site that could play a role in CR adaptation. When phosphorylated, tyrosine 304 
decreases respiration.  Tyrosine 304 is close to the binuclear reaction site in subunit I, therefore it 
could interact directly with active site kinetics in order to slow the reaction rate.  Interestingly, 
tyrosine 304, like serine 58, is phosphorylated in the presence of high cAMP levels.[47]  So, both 
an inhibitory and activating phosphorylation are caused by an increase in cAMP.  One potential 
explanation is the different compartments involved in the phosphorylations.  Serine 58 is located 
in the matrix and is regulated by mitochondrial cAMP levels and PKA, while tyrosine 304 is in 
the intermembrane space, and thus would be under the control of cytosolic cAMP levels and 
kinases.  Therefore, the two responses could be separated.   
 
Connections with Other Pathways in CR 
More research needs to be done to elucidate the exact phosphorylation sites changed 
during CR and their effects on respiration and NO production.  This is a path with large 
pharmacological relevance, for if these changes could be induced with a small molecule, it could 
delay aging and onset of age-related disorders.  Such attempts have already been made, most 
prominently with the compound resveratrol. Resveratrol is a polyphenol found in the skins of 
certain fruits, including grapes, that was found to increase the lifespan of C. elegans and other 
lower eukaryotes, and induce intracellular changes reminiscent of CR.[48][49] In mice, it was 
found to delay the aging phenotype, although it did not extend lifespan.  It was initially thought 
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that resveratrol was an activator of Sir2, as increased Sir2 activity followed resveratrol 
administration.[50]  However, evidence now indicates that resveratrol instead inhibits cAMP 
phosphodiesterases, which indirectly activates Sir2, PGC-1!, and AMP-activated protein kinase 
(AMPK).  Once evidence shifted away from resveratrol directly acting on Sir2, evidence also 
started to emerge that undermined Sir2’s central role in CR and nutrient sensing abilities. 
Overexpression of Sir2 alone did not increase lifespan in mice, and Sir2 activation by rising 
NAD+ concentration alone has been questioned.[51]   
As Sir2’s role fell, AMPK’s began to rise, with mounting evidence supporting its role in 
CR adaptations.  Resveratrol’s positive effects on mice were abolished in those lacking AMPK 
and AMPK appears to be a key energy regulator, as it responds to AMP, ADP, and ATP levels in 
relation to one another as a means of regulating cellular energy charge.[52][51] This again brings 
up the changes in ATP and ADP seen during a shift to CR, as ATP:ADP increased 1.6-fold 
higher in CR yeast than non-CR yeast.  Although previous focus was on the effect of ATP and 
ADP on Cco regulation, this is another mechanism of energy sensing within the cell that could 
mediate the adaptation to CR.  
 
NO’s Role in Caloric Restriction 
Another missing piece of the puzzle involves what role NO plays in CR.  During 
hypoxia, NO helps stabilize HIF-1!, which allows it to induce hypoxic gene induction.[53]  Such 
a mechanism is equally plausible in CR.  Although a separate nitric oxide synthase in yeast has 
yet to be identified, they do exist in mammals, and CR has been found to also increase 
expression of the endothelial nitric oxide synthase (eNOS) in mice, which results in increased 
mitochondrial biosynthesis. Many of the effects associated with CR, like increased respiration, 
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were lost when eNOS activity was eradicated.[54]  So NO evidently plays a key role in 
mediating the changes induced by CR.  Elucidating the precise mechanism by which NO acts 
would greatly increase understanding of CR.   
The vital role of NO in CR also introduces a new site of pharmacologic intervention.  
Does increasing NO by added NO donors during conditions of non-CR also lead to increases in 
lifespan?  The answer is not straightforward.  In certain conditions, addition of NO donors 
induced some aspects reminiscent of CR and led to slight lifespan increases in yeast.[3]  In 
mammals, L-arginine is a substrate for NOS and administration increases NO production.[55]  In 
humans, L-arginine supplementation has only been tested in patients who suffered myocardial 
infarctions, and it was found to increase mortality.[56]  Whether L-arginine supplementation will 
have any effect, positive or negative, on degenerative diseases and aging has yet to be explored.  
Given the important role of NO, and the numerous cellular mechanisms found in this study to 
regulate its production, it is a question worth exploring. 
 
Conclusion  
Ultimately, the intracellular changes in metabolites, phosphorylation, and protein levels 
each paint part of the picture.  As CR induces a metabolic reprogramming of the cell, it fits that 
there are numerous pathways and mechanisms responsible for the adaptations.  Though it is 
appealing to find a singular causative agent for how CR delays aging, like Sir2 or AMPK, such a 
quest undermines the high complexity and regulation of the cell.   Future research examining the 
relationship between dynamic phosphorylation and allosteric regulation of respiration and NO 
production will provide vital insights into cellular adaptations to CR, and into the degenerative 
changes seen in aging and diseased cells. 
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